Hostname: page-component-84b7d79bbc-tsvsl Total loading time: 0 Render date: 2024-07-25T20:14:03.232Z Has data issue: false hasContentIssue false

Vitamin D and cardiovascular disease

Published online by Cambridge University Press:  11 September 2013

Get access

In a nutshell

Vitamin D does appear to be an important factor in CVD, including hypertension, but clinical application (apart from renal hypertension) is unproven.

Even so, vitamin D is so important to good health, and inadequate status so common, that clinicians should always bear it in mind, particularly in those with less sun exposure.

Type
Brief Report
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Zittermann, A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Feb 28; [Epub ahead of print]Google Scholar
2. Holick, MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006 Mar;81(3):353–73.CrossRefGoogle ScholarPubMed
3. Tangpricha, V. et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002 Jun 1;112(8):659–62.CrossRefGoogle ScholarPubMed
4. Simonelli, C. et al. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin. 2005 Jul;21(7):1069–74.CrossRefGoogle Scholar
5. Zittermann, A. et al. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005 Oct;94(4):483–92.CrossRefGoogle ScholarPubMed
6. Norman, PE. et al. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):3946.CrossRefGoogle ScholarPubMed
7. Grant, WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Feb 28; [Epub ahead of print]Google Scholar
8. Watson, KE. et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997 Sep 16;96(6):1755–60.CrossRefGoogle ScholarPubMed
9. Arad, Y. et al. Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis. 1998;9(8):513–8.CrossRefGoogle Scholar
10. Poole, KE. et al. Reduced vitamin D in acute stroke. Stroke. 2006 Jan;37(1):243–5.CrossRefGoogle ScholarPubMed
11. Liu, S. et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Dec;28(12):2926–32.CrossRefGoogle ScholarPubMed
12. Forman, JP. et al. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005 Oct;46(4):676–82.CrossRefGoogle ScholarPubMed
13. Helman, A. Calcium and blood pressure. Arbor Clin Nutr Updates 1999 (Jan);59:12.Google Scholar
14. Calvo, MS. et al. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1710S–6S.CrossRefGoogle ScholarPubMed
15. Weishaar, RE. et al. Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. Am J Physiol. 1987 Dec;253(6 Pt 1):E675–83.Google ScholarPubMed
16. Zemel, MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr. 2001 Oct;20(5 Suppl):428S435S.CrossRefGoogle ScholarPubMed
17. Jespersen, B. et al. Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension. Am J Hypertens. 1998 Jun;11(6 Pt 1):659–66.CrossRefGoogle ScholarPubMed
18. Mitsuhashi, T. et al. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest. 1991 Jun;87(6):1889–95.CrossRefGoogle ScholarPubMed
19. Wakasugi, M. et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991 Aug;42(2):127–36.CrossRefGoogle ScholarPubMed
20. Li, YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003 Feb 1;88(2):327–31.CrossRefGoogle ScholarPubMed
21. Burgess, ED. et al. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens. 1990 Dec;3(12 Pt 1):903–5.CrossRefGoogle Scholar
22. Argiles, A. et al. Blood pressure is correlated with vitamin d(3) serum levels in dialysis patients. Blood Purif. 2002;20(4):370–5.CrossRefGoogle ScholarPubMed
23. Jorde, R. et al. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study. Am J Clin Nutr. 2000 Jun;71(6):1530–5.CrossRefGoogle ScholarPubMed
24. Lind, L. et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995 Sep;8(9):894901.CrossRefGoogle ScholarPubMed
25. Scragg, R. et al. Serum 25-hydroxycholecalciferol concentration in newly detected hypertension. Am J Hypertens. 1995 Apr;8(4 Pt 1):429–32.CrossRefGoogle ScholarPubMed
26. Pfeifer, M. et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001 Apr;86(4):1633–7.Google ScholarPubMed
27. Scragg, R. et al. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995 Sep;49(9):640–6.Google ScholarPubMed
28. Lind, L. et al. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988;223(3):211–7.CrossRefGoogle ScholarPubMed
29. Lind, L. et al. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens. 1989 Jan;2(1):20–5.CrossRefGoogle ScholarPubMed
30. Krause, R. et al. Ultraviolet B and blood pressure. Lancet. 1998 Aug 29;352(9129):709–10.CrossRefGoogle ScholarPubMed